Immun Inflamm Dis, 2023 · DOI: 10.1002/iid3.1015 · Published: September 5, 2023
This study investigates the therapeutic potential of albiflorin (AF) in alleviating inflammation and oxidative stress in rats with spinal cord injury (SCI). The study found that AF could alleviate motor dysfunction and neuron cell loss in SCI-induced rats. AF was found to attenuate inflammatory responses by reducing oxidative stress and activating the Nrf2/HO-1 pathway. This suggests a mechanism by which AF could protect against the aggravation of SCI. The anti-inflammatory activity of AF was counteracted by depleting antioxidant capacity. This highlights the importance of oxidative stress reduction in the therapeutic effect of AF.
Albiflorin has the potential to be developed as a therapeutic agent for spinal cord injury, offering a novel approach to mitigate neurodegeneration and improve motor function.
The Nrf2/HO-1 pathway can be targeted for drug development to enhance antioxidant responses and reduce inflammation in SCI and other neurodegenerative conditions.
This study supports the potential of Traditional Chinese Medicine in treating complex conditions like SCI, highlighting the importance of further research in this area.